About Baylor Genetics
Baylor Genetics is a private company based in Houston, Texas, incorporated in 2025 in Delaware. It has reported $49,999,986 raised in one offering on Form D since July 2026. Its chief executive is Kengo Takishima.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Jul 1, 2026 | Jul 16, 2026 | $49,999,986of $99.9M target | 13 | $3.8M | EquityRule 506(b) | Form D ↗ |
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Baylor Genetics's Form D filed Jul 16, 2026.
BL
Brendan Lee
Scientific Advisory Board Chair
XC
Xiangmin Cui
Director
Also a director at ImmPACT Bio USA, LevitasBio and SunnyBay BioTech and an executive officer, director and promoter at Decheng Capital Global Life.
JK
GI
Goki Ishikawa
Director
VT
Victor Tong
Director
DB
David Berger
Chief Legal Officer and Secretary
Sources
- SECBaylor Genetics Holdings, Inc. filing history
- CompanyContact Us
- CompanyAbout Baylor Genetics
- CompanyOur People